
Planet Labs' stock has fallen nearly 70% over the past six months, largely due to investor shifts following SpaceX's IPO and some revenue timing issues. Despite this, the company shows strong revenue growth of 58% year-over-year and a backlog exceeding $900 million. Analysts remain bullish, with some targeting a stock price of $50, implying potential gains over 250%. The key risks include slowing backlog growth and capital shifts, but solid defense contracts and new satellite technology support optimism for recovery.
Planet Labs shares have dropped significantly, with all recent Pluang order activity being sell orders. On Pluang, PL trades at USD 12.70, down 0.16% for the day, with a market cap of $4.63 billion and a 52-week low of $11.16 as of Nov 17, 2026 20:42 WIB.